DIANTHUS THERAPEUTICS INC (DNTH) Stock Income Statement
NASDAQ:DNTH - Nasdaq - US2528281080 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 5.37M | 2.83M | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 88.27M | 51.00M | 80.90M | 74.69M | 78.70M | |||
| Research and Development | 65.43M | 32.84M | 55.14M | 46.77M | 50.62M | |||
| Selling, General, and Administrative Expenses | 22.84M | 18.16M | 25.76M | 27.93M | 28.09M | |||
| Operating Income | -82.90M | -48.17M | -80.90M | -74.69M | -78.70M | |||
| Interest Income/Expense | 16.00M | 4.68M | 4.44M | 3.56M | 3.77M | |||
| Other Income/Expense | -191.00K | -60.00K | N/A | N/A | N/A | |||
| Income Before Taxes | -67.09M | -43.55M | -76.46M | -71.14M | -74.94M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -67.09M | -43.55M | -76.46M | -71.14M | -74.94M | |||
| EBITDA | -82.82M | -48.11M | -78.97M | -72.67M | -76.72M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.49 | -8.45 | -20.61 | -20.74 | -27.25 | |||
| Non GAAP EPS | -2.50 | -12.97 | -20.64 | -1.31 | -1.74 | |||
| Statistics | ||||||||
| Profit Margin | -1250.32% | -1541.22% | N/A | N/A | N/A | |||
| Operating Profit Margin | -1544.99% | -1704.67% | N/A | N/A | N/A | |||
All data in USD